Announcements Trials
Browse Landscape

Phase

Phase 1 524Phase 1/2 271Phase 2 135Phase NA 106Phase EARLY_PHASE1 38Phase 3 16Phase 2/3 4Phase 4 3

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 86Thoracic 45Other hematologic neoplasm 38Genitourinary 37Lymphoid 33Head & Neck 29Gynecologic 29Breast 23CNS 17Dermatologic 15Sarcoma 11Plasma cell 10Endocrine 9Tumor-Agnostic 8Myeloid 7Other solid neoplasm 4Other 3NET 3Classical hematology 3Other neoplasm 1

Conditions

Retinoblastoma 1Resectable MMR-deficient Solid Tumors 1All Solid Tumors 1Advanced Intrahepatic Cholangiocarcinoma 1

Interventions

balstilimab 1Vincristine 1Topotecan 1Platinum Compounds 1Melphalan 1Hyperthermia, Induced 1Etoposide 1Drug Therapy 1Cryotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Other solid neoplasm × 1 year × Clear all
NCT06279130 2026-03-05

NEOASIS

The Netherlands Cancer Institute

Phase 2/3 Recruiting
133 enrolled
Other solid neoplasm

Resectable MMR-deficient Solid Tumors

NCT03686202 2026-02-09

MET4-IO

University Health Network, Toronto

Phase 2/3 Active not recruiting
65 enrolled
Other solid neoplasm

All Solid Tumors

NCT04353375 2025-12-31

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Hutchmed

Phase 2/3 Recruiting
235 enrolled
GastrointestinalOther solid neoplasm

Advanced Intrahepatic Cholangiocarcinoma

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting
225 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡